Affimed NV (NASDAQ: AFMD) is running for the top in the market this morning, and for good reason. The company announced positive initial clinical data surrounding AFM13, a drug under development for the treatment of cancer. Here’s the scoop: Affimed Announces Positive Clinical Data In the press release, Affimed announced positive initial data from a … Read more
Silo Pharma Inc (OTCQB: SILO) is setting the stage for a strong day in the market this morning, and for good reason. The company announced that it has finalized a key agreement. Here’s what’s happening: Silo Pharma Announces Finalized Agreement In a press release issued early this morning, Silo Pharma announced that it finalized an … Read more
Titan Medical Inc. (NASDAQ: TMDI) is rocketing in the market this morning, squeezing the shorts out of their positions as an analyst initiation takes center stage. Here’s what’s going on: Titan Medical Gains Analyst Coverage In a note to investors, Oppenheimer announced that it has initiated coverage on Titan Medical, and it’s done so in … Read more
Seelos Therapeutics Inc (NASDAQ: SEEL) is headed for the top in the market this morning, and for good reason. The company announced that it has entered into a strategic device partnership, which could open the door to opportunities. Here’s what’s going on: Seelos Therapeutics Announces Strategic Partnership In the press release, Seelos said that it … Read more
Brooklyn ImmunoTherapeutics (NYSEAMERICAN: BTX) is screaming for the top in the market this morning, following up on the strong gains seen out of the stock yesterday. With no news, either by way of press release, or SEC filing, many are wondering what the reason for the move is. Ultimately, it seems to be a concerted … Read more
CEL-SCI Corporation (NYSEAMERICAN: CVM) is rocketing in the market this morning, following up on the recent gains we’ve seen in the stock. Interestingly, no press releases or SEC filings have hit the tape. So, what’s going on? Investors are expecting a massive move this month following a data release that has been years in the … Read more
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is tumbling in the market this morning, falling more than 10% in the premarket hours. The declines come after the company announced that it has received a Complete Response Letter, or CRL, from the FDA surrounding a recent supplemental New Drug Application, or sNDA. While there’s a good reason for … Read more
Chembio Diagnostics Inc (NASDAQ: CEMI) is flying in the market this morning after the company issued news on Friday surrounding the commercial launch of a point-of-care COVID-19/Flu A&B test. Here’s what’s happening: Chembio Diagnostics Announces Commercial Launch In the press release, Chembio Diagnostics said that it will be launching its in-licensed rapid point-of-care COVID-19/Flu A&B … Read more
Seneca Biopharma Inc (NASDAQ: SNCA) is headed for the top in the market this morning, but with no press releases or SEC filings, the big question is, “Why?” The gains seem to be related to a proposed merger with Leading BioSciences that investors will vote on this Friday. Here’s what’s going on: Leading BioSciences CEO … Read more
Ocugen Inc (NASDAQ: OCGN) is screaming for the top in the market this morning, but with no press releases or SEC filings, many are wondering what’s going on. The gains seem to be related to a Fireside Chat that will take place at 10:00 a.m. this morning. Here’s what’s going on: Investors Look Forward To … Read more